September 13, 2017

More Communication Needed on New Trial Designs

The FDA “needs to engage in more communication between sponsors, investigators, IRBs, and other stakeholders involved in the development program” regarding new trial designs, FDA Commissioner Scott Gottlieb said in prepared remarks to the RAPS 201...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight